◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

AURINIA PHARMACEUTICALS INC.

CIK: 1600620 SIC: 2834
$283.06M
Revenue
$287.20M
Net Income
88.46%
Gross Margin
37.06%
Op. Margin
$182.50M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 14 of 15 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
+ Total Revenue $77.11M $73.47M $70.01M $62.47M $59.87M $67.77M $57.19M $50.30M $45.09M $54.52M $41.49M $34.41M $28.43M $55.78M
Revenue Growth % (YoY) 28.8% 8.4% 22.4% 24.2% 32.8% 24.3% 37.8% 46.2% 58.6% -2.3% nan% nan% nan% nan%
Cost of Revenue $8.80M $8.18M $7.12M $8.57M $5.55M $6.04M $8.91M $7.75M $5.39M $6.77M $1.56M $421.00K $1.36M $2.45M
+ Gross Profit $68.31M $65.29M $62.89M $53.89M $54.31M $61.74M $48.28M $42.55M $39.70M $47.75M $39.93M $33.99M $27.07M $53.33M
Gross Margin % 88.6% 88.9% 89.8% 86.3% 90.7% 91.1% 84.4% 84.6% 88.0% 87.6% 96.2% 98.8% 95.2% 95.6%
Operating Expenses $43.88M $43.72M $49.92M $40.62M $61.54M $56.02M $58.70M $63.56M $74.77M $70.78M $57.66M $63.99M $56.53M $65.28M
Research & Development $10.89M $8.44M $7.43M $5.74M $8.11M $3.05M $4.08M $5.55M $10.23M $13.61M $12.65M $13.16M $9.87M $10.97M
+ Operating Income $33.24M $29.75M $20.08M $21.85M $-1.67M $11.75M $-1.51M $-13.25M $-29.67M $-16.26M $-16.17M $-29.58M $-28.10M $-9.50M
Operating Margin % 43.1% 40.5% 28.7% 35.0% -2.8% 17.3% -2.6% -26.3% -65.8% -29.8% -39.0% -86.0% -98.8% -17.0%
Interest Expense $1.05M $1.10M $1.12M $1.07M $1.15M $1.21M $1.20M $1.28M $1.31M $1.40M $65.00K - - -
Interest Income $3.50M $3.32M $3.19M $3.57M $3.99M $4.27M - - $4.57M - - - - -
Income Before Tax $35.69M $31.96M $22.16M $24.35M $1.17M $14.81M $1.48M $-10.01M $-26.42M $-13.15M $-12.13M $-25.77M $-25.19M $-8.04M
Income Tax Expense $-175.10M $411.00K $643.00K $1.00M $-256.00K $457.00K $756.00K $739.00K $459.00K $298.00K $-642.00K $436.00K $855.00K $954.00K
+ Net Income $210.79M $31.55M $21.51M $23.34M $1.43M $14.35M $722.00K $-10.75M $-26.88M $-13.45M $-11.49M $-26.21M $-26.05M $-8.99M
Net Margin % 273.4% 42.9% 30.7% 37.4% 2.4% 21.2% 1.3% -21.4% -59.6% -24.7% -27.7% -76.2% -91.6% -16.1%
Basic EPS 1.57 0.24 0.16 0.17 0.01 0.10 0.01 -0.07 -0.18 -0.09 -0.08 -0.18 -0.18 -0.06
Diluted EPS 1.52 0.23 0.16 0.16 0.01 0.10 0.01 -0.07 -0.18 -0.09 -0.08 -0.18 -0.18 -0.06
Basic Shares Outstanding - 131.8M 134.9M 138.9M -296K 143.1M 143.3M 144.0M 151K 142.8M 142.8M 142.6M 84K 141.9M
Diluted Shares Outstanding - 136.0M 137.5M 143.2M 1.2M 145.7M 144.1M 144.0M 151K 142.8M 142.8M 142.6M 84K 141.9M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Cash & Cash Equivalents $80.16M $72.89M $52.91M $66.11M $83.40M $36.63M $33.27M $63.91M $48.76M $45.56M $81.39M $88.33M $94.09M $85.34M
Inventory $45.69M $44.79M $46.50M $46.20M $39.23M $38.71M $38.85M $39.76M $39.70M $32.82M $33.16M $31.75M $24.75M $25.32M
Other Current Assets $1.08M $301.00K $665.00K $781.00K $1.13M $2.70M $6.98M $2.00M $1.03M $1.65M $1.21M $1.23M $1.33M $3.81M
Total Current Assets $491.97M $438.74M $408.97M $405.76M $446.60M $440.46M $409.67M $398.22M $424.80M $426.47M $415.91M $423.65M $442.54M $459.70M
Property Plant & Equipment $2.11M $2.27M $2.42M $2.58M $2.73M $2.89M $3.04M $3.20M $3.35M $3.50M $3.65M $3.84M $3.65M $3.76M
Intangible Assets $3.76M $3.90M $4.05M $4.16M $4.36M $4.51M $4.62M $4.76M $4.98M $5.26M $5.68M $6.10M $6.42M $6.84M
Other Non-current Assets $93.00K $93.00K $93.00K $823.00K $823.00K $868.00K $867.00K $1.50M $1.52M $1.52M $1.52M $13.36M $13.34M $13.05M
Total Assets $751.59M $527.53M $502.56M $504.85M $550.64M $549.36M $523.53M $516.63M $548.06M $555.01M $548.90M $451.76M $470.86M $488.29M
Accounts Payable $3.31M $2.21M $3.31M $4.22M $5.19M - - - $4.33M - - - - -
Accrued Liabilities $66.62M $49.54M $49.70M $42.35M $64.97M - - - $50.06M - - - - -
Deferred Revenue $3.72M $4.60M $5.50M $4.59M $11.00M $4.30M $4.37M $4.91M $4.81M $4.66M $3.23M $3.16M $3.15M -
Other Current Liabilities $2.48M $2.50M $2.54M $1.70M $1.53M $1.59M $1.16M $1.15M $2.39M $2.61M $2.09M $1.98M $2.03M $724.00K
Total Current Liabilities $93.72M $76.22M $78.27M $68.41M $97.76M $78.61M $76.90M $71.05M $77.19M $73.89M $61.66M $42.05M $46.11M $41.77M
Other Non-current Liabilities $6.70M - - - $11.11M $10.84M $10.94M $12.29M $10.91M $10.34M $8.71M $12.32M $12.17M $15.83M
Total Liabilities $170.26M $161.76M $167.26M $154.66M $173.17M $161.36M $158.91M $157.16M $170.11M $163.14M $156.61M $61.35M $65.42M $64.87M
Retained Earnings $-649.37M $-860.16M $-891.71M $-913.23M $-936.57M $-938.00M $-952.35M $-953.07M $-942.32M $-915.45M $-902.00M $-890.51M $-864.30M $-838.26M
Total Stockholders Equity $581.33M $365.77M $335.30M $350.19M $377.48M $388.00M $364.62M $359.48M $377.95M $391.88M $392.29M $390.41M $405.44M $423.43M
Total Liabilities & Equity $751.59M $527.53M $502.56M $504.85M $550.64M $549.36M $523.53M $516.63M $548.06M $555.01M $548.90M $451.76M $470.86M $488.29M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Net Income $210.79M $31.55M $44.86M $23.34M $1.43M $4.32M $722.00K $-10.75M $-26.88M $-51.15M $-11.49M $-26.21M $-26.05M $-8.99M
Depreciation & Amortization $4.86M $14.59M $9.72M $4.86M $4.86M - - - - - - - - -
Stock-based Compensation $6.73M $7.95M $2.03M $-3.41M $8.95M $22.65M $14.32M $5.74M $11.77M $33.54M $21.73M $9.47M $6.90M $25.40M
Change in Receivables $10.73M $-5.82M $3.55M $3.81M $61.00K $12.39M $1.43M $4.82M $-13.86M $24.46M $6.02M $5.56M $-28.28M $26.36M
Change in Inventory $897.00K $5.57M $7.28M $6.97M $514.00K $-991.00K $-852.00K $56.00K $6.88M $8.98M $8.40M $6.99M $614.00K $8.46M
Change in Payables $1.10M $-2.97M $-1.88M $-974.00K $-3.69M - - - - - - - - -
Operating Cash Flow $45.67M $89.99M $45.54M $1.30M $30.11M $14.27M $-2.75M $-18.60M $14.31M $-47.77M $-34.50M $-31.67M $10.45M $-89.98M
Purchases of Investments $182.03M $344.62M $237.41M $91.99M $84.69M $461.14M $318.13M $121.26M $144.29M $379.21M $256.44M $142.40M $120.81M $403.18M
Investing Cash Flow $-36.76M $3.99M $17.76M $31.03M $39.22M $39.00K $10.61M $49.23M $-6.26M $-449.00K $19.25M $24.86M $-3.02M $-57.61M
Stock Issued $355.00K $401.00K $401.00K - $381.00K - - - - - - - - -
Stock Repurchased - $98.16M $89.48M $46.92M $21.80M $18.43M $18.43M $12.30M - - - - - -
Financing Cash Flow $-1.89M $-104.22M $-93.73M $-49.34M $-23.05M $-26.05M $-23.32M $-15.05M $-5.58M $447.00K $2.78M $1.64M $688.00K $1.75M
Net Change in Cash $7.02M $-10.24M $-30.43M $-17.00M $46.29M $-11.73M $-15.47M $15.58M $2.48M $-47.77M $-12.46M $-5.17M $8.12M $-145.85M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $73.47M - $205.94M -
Cost of Revenue $8.18M - $23.87M -
Operating Expenses $43.72M - $134.27M -
Research & Development $8.44M - $21.61M -
Operating Income $29.75M - $71.67M -
Interest Expense $1.10M - $3.28M -
Interest Income $3.32M - $10.07M -
Income Before Tax $31.96M - $78.47M -
Income Tax Expense $411.00K - $2.06M -
Net Income $31.55M $722.00K $76.41M -
Basic EPS 0.24 - 0.57 -
Diluted EPS 0.23 - 0.55 -
Basic Shares Outstanding $131.81M - $135.16M -
Diluted Shares Outstanding $136.01M - $138.96M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $72.89M -
Inventory $44.79M $39.23M
Other Current Assets $301.00K $1.13M
Total Current Assets $438.74M $446.60M
Property Plant & Equipment $2.27M $2.73M
Intangible Assets $3.90M $4.36M
Other Non-current Assets $93.00K $823.00K
Total Assets $527.53M $550.64M
Accounts Payable $2.21M $5.19M
Accrued Liabilities $49.54M $64.97M
Deferred Revenue $4.60M $11.00M
Other Current Liabilities $2.50M $1.53M
Total Current Liabilities $76.22M $97.76M
Total Liabilities $161.76M $173.17M
Retained Earnings $-860.16M $-936.57M
Total Stockholders Equity $365.77M $377.48M
Total Liabilities & Equity $527.53M $550.64M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $31.55M $722.00K $76.41M -
Depreciation & Amortization - - $14.59M -
Stock-based Compensation - - $7.95M -
Change in Receivables - - $-5.82M -
Change in Inventory - - $5.57M -
Change in Payables - - $-2.97M -
Operating Cash Flow - - $89.99M -
Purchases of Investments - - $344.62M -
Investing Cash Flow - - $3.99M -
Stock Issued - - $401.00K -
Stock Repurchased - - $98.16M -
Financing Cash Flow - - $-104.22M -
Net Change in Cash - - $-10.24M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...